ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED

Alibaba Health Information Technology Limited

241 BMG0171K1018

Drug Retailers

Market Closed - Hong Kong S.E. Other stock markets 09:08:34 17/07/2024 BST			5-day change	1st Jan Change
3.42 ^HKD	+8.57%		+10.68%	-19.34%

05-28	Hong Kong Stocks Stayed Flat Despite Shanghai’s Property Cuts, Beijing’s Huge Investment Plan	MT
05-28	Alibaba Health Shares Rise on Earnings Beat	DJ

Alibaba Health Information Technology Limited Announces Change of Address of Principal Place of Business in Hong Kong

January 29, 2015 at 11:19 am

The board of directors of Alibaba Health Information Technology Limited announced that the principal place of business of the company in Hong Kong
will be changed to 26/F Tower One, Times Square, 1 Matheson Street, Causeway Bay, Hong Kong with effect from January 29, 2015.

Latest news about Alibaba Health Information Technology Limited

Hong Kong Stocks Stayed Flat Despite Shanghai’s Property Cuts, Beijing’s Huge Investment Plan	05-28	MT
Alibaba Health Shares Rise on Earnings Beat	05-28	DJ
Alibaba Health's Fiscal Year 2024 Profit, Revenue Rise; Shares Rise 13%	05-28	MT
Alibaba Health Information Technology Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-27	CI
Alibaba Health Refutes Rumors of Purchase of Telemedicine Platform HaoDF	04-03	MT
Alibaba Health Information Technology Limited and Alibaba.com Enter Shared Services Agreement	03-28	CI
Alibaba Health Information Technology Limited Announces 2025-2027 Software Services Framework Agreement	03-28	CI
Alibaba Health Shareholders to Vote March 26 on Contract Renewal with Affiliates	03-07	MT
Alibaba Health to Renew Marketing, Technical Services Deals with Affiliates	02-05	MT
Alibaba Health Acquires Parent's Tmall Healthcare Marketing Services	01-17	MT
China Economic Data Blunts Asian Stock Markets	01-17	MT
Rate Outlook Lifts Asian Stock Markets	11-30	MT
Alibaba Health to Buy Parent's Tmall Healthcare Marketing Services for HK$13.5 Billion; Shares Fall 4%	11-30	MT
Alibaba Health Information Technology Names Chief Executive Officer	11-29	MT
Alibaba Health Posts 82% Jump in Fiscal H1 Profit	11-28	MT
Alibaba Health in $1.73 bln deal for some Alibaba marketing services	11-28	RE
Alibaba Health Information Technology to buy AJK Technology for $1.73 billion	11-28	RE
Alibaba Health Information Technology Limited Announces Executive Changes	11-28	CI
Alibaba Health Information Technology Limited Reports Earnings Results for the Half Year Ended September 30, 2023	11-28	CI
Alibaba Health Information Technology Limited agreed to acquire Hangzhou Jingzhun Health Information Technology Co., Ltd. from Alibaba Group Holding Limited for HKD13.5 billion.	11-27	CI
Alibaba Health Information Technology Limited Appoints Xu Haipeng as Non-Executive Director	19/10/23	CI
Interest Rates, US Jobs Outlook Weigh on Asian Stock Markets	06/10/23	MT
Hong Kong stocks rise ahead of US payrolls data, China market reopen	06/10/23	RE
China Proposes Easing of Cross-Border Data Controls -- Update	29/09/23	DJ
Wall Street Cues, Interest Rates Roil Asian Stock Markets	29/09/23	MT

Chart Alibaba Health Information Technology Limited

Duration

Period

Chart Alibaba Health Information Technology Limited

More charts

Company Profile

Alibaba Health Information Technology Limited is specialized in the direct sale of pharmaceuticals. The turnover is divided across the following activities: - direct sale of pharmaceuticals (85.2%); - online sale of pharmaceuticals(12.7%); - direct healthcare services (1.8%); - online healthcare services and monitoring of pharmaceuticals (0.3%). The turnover is divided into the revenue sources of product sales (80.8%) and services (19.2%). The geographical breakdown of the turnover is as follows: mainland China (95.8%) and Hong Kong (4.2%).

Sector

Drug Retailers

Calendar

25/11/2024 - Q2 2025 Earnings Release (Projected)

Related indices

HONG KONG HANG SENG

More about the company

Income Statement Evolution

More financial data

Ratings for Alibaba Health Information Technology Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.18 CNY

Average target price

4.637 CNY

Spread / Average Target

+45.78%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-19.34%	6.49B
WALGREENS BOOTS ALLIANCE, INC.	-54.37%	10.13B
JD HEALTH INTERNATIONAL INC.	-44.50%	8.54B
MATSUKIYOCOCOKARA & CO.	-3.00%	6.29B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+92.00%	5.25B
NAHDI MEDICAL COMPANY	-2.48%	4.61B
CLICKS GROUP LIMITED	+6.16%	4.55B
YIFENG PHARMACY CHAIN CO., LTD.	-31.43%	3.72B
REDCARE PHARMACY NV	+6.00%	3.1B
SAUDI CHEMICAL HOLDING COMPANY	+156.94%	2.5B

Other Drug Retailers